Skip to main content
. 2021 Sep 9;12:700903. doi: 10.3389/fimmu.2021.700903

Table 1.

Cell populations of PBMCs in MP4-infected and 6-OHDA-treated mice at day 6 post-infection.

Mouse PBMCs
Medium + Vehicle (N = 5) Virus + Vehicle (N = 5) Virus + 6-OHDA (N = 5)
Absolute events
(x 103 cell/mL)
% Absolute events
(x 103 cell/mL)
% Absolute events (x 103 cell/mL) %
CD3+CD4+ 610.27 (157.35) 20.8 (3.90) 92.54 (19.44)a 32.58 (6.20) 574.86 (184.40)c 42.60 (8.75)
CD3+CD8+ 206.38 (73.15) 5.81 (0.79) 42.75 (15.67) 13.56 (1.79)a 178.51 (48.79)c 13.52 (1.14)d
CD19+ 224.33 (68.95) 16.75 (4.95) 12.65 (3.74)b 17.15 (4.30) 73.69 (28.88) 19.26 (0.96)
CD3-NK1.1+ 68.32 (12.86) 3.54 (1.13) 8.45 (4.38)a 6.28 (2.80) 38.47 (15.87) 7.62 (3.28)
CD3+NK1.1+ 17.87 (2.61) 3.47 (0.69) 7.39 (3.49) 4.76 (1.70) 32.40 (10.36)c 8.75 (5.58)
CD11b+Ly-6C+ 77.95 (15.54) 11.24 (2.80) 89.04 (23.56) 52.64 (8.37)b 106.48 (26.89) 38.48 (4.08)
CD11b+Gr-1+ 73.54 (10.61) 11.99 (4.27) 78.91 (25.84) 46.40 (9.94)a 94.51 (24.24) 34.00 (3.23)

aP < 0.05, for the difference between Medium + Vehicle treated mice and Virus + Vehicle treated mice; bP < 0.01, for the difference between Medium + Vehicle treated mice and Virus + Vehicle treated mice; cP < 0.05, for the difference between Virus + Vehicle treated mice and Virus + 6-OHDA treated mice; dP < 0.05, for the difference between Medium + Vehicle treated mice and Virus + 6-OHDA treated mice. The data shown are the mean (SEM) values and analyzed by Kruskal-Wallis test.